Organ dysfunction as a new standard for defining sepsis

Seitaro Fujishima

研究成果: Review article査読

54 被引用数 (Scopus)


Despite advances in intensive care and the widespread use of standardized care included in the Surviving Sepsis Campaign Guidelines, sepsis remains a leading cause of death, and the prevalence of sepsis increases concurrent with the aging process. The diagnosis of sepsis was originally based on the evidence of persistent bacteremia (septicemia) but was modified in 1992 to incorporate systemic inflammatory response syndrome (SIRS). Since then, SIRS has become the gold standard for the diagnosis of sepsis. In 2016, the Society of Critical Care Medicine and the European Society of Intensive Care Medicine published a new clinical definition of sepsis that is called Sepsis-3. In contrast to previous definitions, Sepsis-3 is based on organ dysfunctions and uses a sequential organ failure (SOFA) score as an index. Thus, patients diagnosed with respect to Sepsis-3 will inevitably represent a different population than those previously diagnosed. We assume that this drastic change in clinical definition will affect not only clinical practice but also the viewpoint and focus of basic research. This review intends to summarize the pathophysiology of sepsis and organ dysfunction and discusses potential directions for future research.

ジャーナルInflammation and Regeneration
出版ステータスPublished - 2016

ASJC Scopus subject areas

  • 免疫学
  • 免疫アレルギー学
  • 細胞生物学


「Organ dysfunction as a new standard for defining sepsis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。